MX2009011041A - Metodos y composiciones para contribuir al tratamiento de canceres. - Google Patents
Metodos y composiciones para contribuir al tratamiento de canceres.Info
- Publication number
- MX2009011041A MX2009011041A MX2009011041A MX2009011041A MX2009011041A MX 2009011041 A MX2009011041 A MX 2009011041A MX 2009011041 A MX2009011041 A MX 2009011041A MX 2009011041 A MX2009011041 A MX 2009011041A MX 2009011041 A MX2009011041 A MX 2009011041A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- compositions
- cancers
- contributing
- treatment
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 abstract 1
- 102000002045 Endothelin Human genes 0.000 abstract 1
- 108050009340 Endothelin Proteins 0.000 abstract 1
- 206010061535 Ovarian neoplasm Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229960004316 cisplatin Drugs 0.000 abstract 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 abstract 1
- 229960004397 cyclophosphamide Drugs 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2285—Endothelin, vasoactive intestinal contractor [VIC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Marine Sciences & Fisheries (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91177307P | 2007-04-13 | 2007-04-13 | |
| PCT/US2008/059949 WO2008127996A1 (en) | 2007-04-13 | 2008-04-10 | Methods and compositions for contributing to the treatment of cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009011041A true MX2009011041A (es) | 2009-11-19 |
Family
ID=39521878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009011041A MX2009011041A (es) | 2007-04-13 | 2008-04-10 | Metodos y composiciones para contribuir al tratamiento de canceres. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP2144607B1 (https=) |
| JP (1) | JP5503528B2 (https=) |
| KR (1) | KR20100016392A (https=) |
| CN (1) | CN101686960A (https=) |
| AR (1) | AR066048A1 (https=) |
| BR (1) | BRPI0810215A2 (https=) |
| CA (1) | CA2683890C (https=) |
| DK (1) | DK2144607T3 (https=) |
| ES (1) | ES2453295T3 (https=) |
| IL (1) | IL201502A (https=) |
| MX (1) | MX2009011041A (https=) |
| RU (1) | RU2009141845A (https=) |
| TW (1) | TWI439266B (https=) |
| WO (1) | WO2008127996A1 (https=) |
| ZA (1) | ZA200907083B (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2502848C (en) * | 2002-10-24 | 2012-10-02 | The Board Of Trustees Of The University Of Illinois | Use of irl-1620 and paclitaxel for preventing and treating breast tumors |
| CA2598439A1 (en) * | 2005-02-22 | 2006-08-31 | The Board Of Trustees Of The University Of Illinois | Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors |
-
2008
- 2008-04-10 EP EP08733184.9A patent/EP2144607B1/en not_active Not-in-force
- 2008-04-10 BR BRPI0810215-5A2A patent/BRPI0810215A2/pt not_active IP Right Cessation
- 2008-04-10 CA CA2683890A patent/CA2683890C/en active Active
- 2008-04-10 KR KR1020097023427A patent/KR20100016392A/ko not_active Ceased
- 2008-04-10 WO PCT/US2008/059949 patent/WO2008127996A1/en not_active Ceased
- 2008-04-10 DK DK08733184.9T patent/DK2144607T3/da active
- 2008-04-10 RU RU2009141845/15A patent/RU2009141845A/ru not_active Application Discontinuation
- 2008-04-10 JP JP2010503210A patent/JP5503528B2/ja not_active Expired - Fee Related
- 2008-04-10 ES ES08733184.9T patent/ES2453295T3/es active Active
- 2008-04-10 CN CN200880020158A patent/CN101686960A/zh active Pending
- 2008-04-10 MX MX2009011041A patent/MX2009011041A/es not_active Application Discontinuation
- 2008-04-11 AR ARP080101522A patent/AR066048A1/es not_active Application Discontinuation
- 2008-04-14 TW TW097113439A patent/TWI439266B/zh not_active IP Right Cessation
-
2009
- 2009-10-12 ZA ZA2009/07083A patent/ZA200907083B/en unknown
- 2009-10-13 IL IL201502A patent/IL201502A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100016392A (ko) | 2010-02-12 |
| IL201502A (en) | 2017-01-31 |
| TWI439266B (zh) | 2014-06-01 |
| ES2453295T3 (es) | 2014-04-07 |
| EP2144607A1 (en) | 2010-01-20 |
| AR066048A1 (es) | 2009-07-22 |
| WO2008127996A1 (en) | 2008-10-23 |
| JP2010523697A (ja) | 2010-07-15 |
| BRPI0810215A2 (pt) | 2014-10-21 |
| ZA200907083B (en) | 2011-01-26 |
| CA2683890A1 (en) | 2008-10-23 |
| AU2008240300A1 (en) | 2008-10-23 |
| JP5503528B2 (ja) | 2014-05-28 |
| CA2683890C (en) | 2020-01-07 |
| RU2009141845A (ru) | 2011-05-20 |
| IL201502A0 (en) | 2010-05-31 |
| DK2144607T3 (da) | 2014-04-07 |
| HK1140145A1 (en) | 2010-10-08 |
| EP2144607B1 (en) | 2014-01-08 |
| TW200904404A (en) | 2009-02-01 |
| CN101686960A (zh) | 2010-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016204376A1 (en) | MicroRNA-based methods and compositions for the diagnosis and treatment of ovarian cancer | |
| WO2008094708A3 (en) | Activin-actriia antagonists and uses for treating or preventing breast cancer | |
| MY188911A (en) | Methods of treating bladder cancer | |
| JO2788B1 (en) | Amido phenoxyendazole compounds beneficial as C-MET inhibitors | |
| PT2155188E (pt) | Métodos e composições para o tratamento de cancro recorrente | |
| EA200901074A1 (ru) | Лечение метастатической стадии рака предстательной железы дегареликсом | |
| MX2009008347A (es) | Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso. | |
| TNSN08401A1 (en) | Methods of treating diagnosing or detecting cancer | |
| WO2007053573A3 (en) | Treatment of cancer with sorafenib | |
| MY159491A (en) | Disubstituted phthalazine hedgehog pathway antagonists | |
| WO2008011519A3 (en) | Amigo-2 inhibitors for treating, diagnosing or detecting cancer | |
| MY146112A (en) | Long-term feed - cancer patient | |
| NZ579478A (en) | Epha3 antibodies for the treatment of solid tumors | |
| JO2833B1 (en) | Amino pyrazole compound | |
| TN2011000166A1 (en) | Disubstituted phthalazine hedgehog pathway antagonists | |
| WO2008061020A3 (en) | Methods of treating, diagnosing or detecting cancer | |
| MX2009012228A (es) | Compuesto de triazolil aminopirimidina. | |
| WO2009108932A3 (en) | Selectin ligands useful in the diagnosis and treatment of cancer | |
| WO2008112290A3 (en) | Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer | |
| WO2008016793A3 (en) | Methods, compositions and articles of manufacture for contributing to the treatment of cancers | |
| FR2945210B1 (fr) | Combinaison antitumorale comprenant l'ave8062 et le sorafenib | |
| TW200727908A (en) | Herbal composition for treating cancer | |
| EA200971103A1 (ru) | Иммуноцитокины для лечения рака в сочетании с химиотерапевтическими агентами | |
| EA200971067A1 (ru) | Триазолиламинопиримидиновые соединения | |
| NZ593169A (en) | Anticancer compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |